Daniel S. Lorrain

Chief Scientific Officer

Chief Scientific Officer at Contineum Therapeutics, Inc., filing insider transactions between 2026-07-08 and 2026-07-09.

Total Purchases

—

0 transactions

Total Sales

$17K

2 transactions

Companies Traded

2 total filings

Active Since

2026-07-08

Last: 2026-07-09

Companies

Contineum Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-09	CTNM	Sale	25	$16.00	$400	135.2K	SEC ↗
2026-07-08	CTNM	Sale	1,015	$16.00	$16K	135.2K	SEC ↗